share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Chattopadhyay Sanat

默沙東 | 4:持股變動聲明-高管 Chattopadhyay Sanat

SEC announcement ·  01/25 05:10
牛牛AI助理已提取核心訊息
Sanat Chattopadhyay, Executive Vice President and President of Merck Manufacturing Division (MMD) at Merck & Co., Inc., completed a purchase of 26,716 shares of common stock on January 22, 2024. The transaction was carried out directly with shares acquired at a price of $119.43 each, totaling approximately $3.19 million. Following this transaction, Chattopadhyay's direct holdings in the company amount to the same number of shares, 26,716. Additionally, Chattopadhyay holds an indirect interest in 130,476 shares through various Grantor Retained Annuity Trusts (GRATs) for the years 2021, 2022, and 2023.
Sanat Chattopadhyay, Executive Vice President and President of Merck Manufacturing Division (MMD) at Merck & Co., Inc., completed a purchase of 26,716 shares of common stock on January 22, 2024. The transaction was carried out directly with shares acquired at a price of $119.43 each, totaling approximately $3.19 million. Following this transaction, Chattopadhyay's direct holdings in the company amount to the same number of shares, 26,716. Additionally, Chattopadhyay holds an indirect interest in 130,476 shares through various Grantor Retained Annuity Trusts (GRATs) for the years 2021, 2022, and 2023.
默沙東公司執行副總裁兼默沙東製造部(MMD)總裁薩納特·查託帕迪亞於2024年1月22日完成了對26,716股普通股的購買。該交易直接進行,以每股119.43美元的價格收購了股票,總額約爲319萬美元。在這筆交易之後,Chattopadhyay在該公司的直接持股量爲相同數量的股份,爲26,716股。此外,查託帕迪亞通過各種設保人留存年金信託(GRAT)在2021年、2022年和2023年間接持有130,476股股票的權益。
默沙東公司執行副總裁兼默沙東製造部(MMD)總裁薩納特·查託帕迪亞於2024年1月22日完成了對26,716股普通股的購買。該交易直接進行,以每股119.43美元的價格收購了股票,總額約爲319萬美元。在這筆交易之後,Chattopadhyay在該公司的直接持股量爲相同數量的股份,爲26,716股。此外,查託帕迪亞通過各種設保人留存年金信託(GRAT)在2021年、2022年和2023年間接持有130,476股股票的權益。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。